Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ARPHION
company
About
Arphion provides oral healthcare non-invasive diagnostic and treatment products for benign diseases such as oral cancer.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $225K
- Industries
- Consulting,Health Care,Health Diagnostics
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Arphion creates non-invasive diagnostics for oral cancers and other benign diseases. They utilize miRNA markers from cheek swabs to diagnose oral squamous cell carcinomas.
Arphion provides its clients with tests as a Laboratory Developed Test (LDT) through a CLIA-certified laboratory to market their products without submission to the FDA for approval or clearance.
Arphion was founded by Dr. Guy Adami, Ph.D. in Illinois, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$225K
ARPHION has raised a total of
$225K
in funding over 2 rounds. Their latest funding was raised on
Mar 3, 2013 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 3, 2013 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
ARPHION is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
